Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer ... reported numerous negative side effects, the drug's labeling was altered by the FDA. Only cancer patients ...
HOUSTON, May 20 (UPI) -- A U.S. study shows Gefitinib, a once-promising drug for treating lung cancer, can enhance hormonal therapy for treating some metastatic breast cancers.
... be more effective than minocycline.
"We will investigate whether a combination of MMP inhibitors with other drugs, such as fenobam, can help mature the synapses in Fragile X mice," Iryna Ethell said.
... approved in 2007. McCammon's team also used the method to identify promising drug candidates for treating H5N1 avian flu.
McCammon's team is now focusing on designing even better ...
... context of a new and highly touted cancer drug. They have found that vastly disparate reactions occur within ... cancer cells.
While TRAIL continues to be a promising drug candidate, its success rate isn ...
... molecules made are being evaluated through the resources of the National Institutes of Health. In the future, promising drugs will then go on to pre-clinical trials.
"The coordinated and recombined ...
... of the study's authors. "But levels were highest in aggressive types, making Met a promising drug target that could help patients that currently have few treatment options."
According to the American ...
... have now invented computational tools that enable other researchers to rapidly and economically answer the 'is it new or not?' question for promising drug targets: ring-shaped nonribosomal peptides.
... small amounts of cancer may have escaped the prostate.
Mostaghel and colleagues feel the most promising drug targets will be inhibitors of CYP17 enzymes, which disrupt the conversion of progesterone ...
Promising drug halts a metal-mediated chemical reaction in the brain
... , mammalian fatty acid synthase is also considered a promising drug target. Although most fat accumulated in ... , making fatty acid synthase an attractive drug target for anti-cancer therapy.
Multi- ...
Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese ... molecule, the target of several anti-cancer drugs.
"Inhibiting either leptin or IGF-1 by ...
... on a daily basis to prevent liver injury, but if it occurs, to use TLR antagonists to treat it."
Promising drugs that have failed clinical trials because of liver toxicity might be resurrected if ...
... seemingly miraculously, by taking L-DOPA or related drugs that mimic the missing dopamine. After a few years ... Ras and ERK do so many things, they are not promising drug targets because blocking them ...
This research, coordinated by the doctors Jesús Prieto, Esther Larrea, Pablo Sarobe, Iranzu González and Rafael Aldabe, has been published in the Journal of Virology; a journal of the American ...
